Figure 1: Treatment with a glucocorticoid receptor antagonist reduces lipolysis and plasma glucose concentrations in T1D rats. | Nature Communications

Figure 1: Treatment with a glucocorticoid receptor antagonist reduces lipolysis and plasma glucose concentrations in T1D rats.

From: FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis

Figure 1

(a–d) Fasting plasma glucose, NEFA, glycerol and insulin concentrations. (e) Hepatic glucose production. (f–g) Whole-body palmitate and glycerol turnover. (h) Liver acetyl CoA. Data are representative of mean±s.e.m. of n=6 per group, with comparisons by the two-tailed unpaired Student's t-test.

Back to article page